نتایج جستجو برای: radio iodine therapy

تعداد نتایج: 771554  

Journal: :Hippokratia 2012
T Aktoz G Durmus-Altun U Usta N Torun A Ergulen I H Atakan

BACKGROUND Ablative radioiodine-131 ((131)I) therapy is used in the standart treatment procedure of thyroid carcinoma and procedures using (131)I represent the majority of Nuclear Medicine therapeutic procedures. The principal route of (131)I excretion after the administration of (131)I is the urine. Amifostine is an organic thiophosphate ester prodrug and the kidney concentrations of the activ...

Dariyush Shahbazi-Gahrouei Ehsan Khodamoradi Kourosh Ziaie Zahra Shahi

  Introduction:  The use of radioactive iodine (131I) has become an important adjunct to the treatment of thyroid cancer and hyperthyroidism. Salivary gland has the ability to concentrate radioactive iodine under normal circumstances. Salivary gland dysfunction and dry mouth are the common side effectsof high-dose radioiodine therapy. The purposeof this stu...

Journal: :The Journal of international medical research 1992
A Zaini A Khir S A Doi S P Chan M Paramsothy B H Khoo

To evaluate the effects of simple compensated fixed-dose iodine-131 therapy for thyrotoxicosis, the long-term results for 74 patients treated with a fixed dose of iodine-131 ranging from 5 to 12 mCi (185 to 444 MBq) were evaluated in the first 2 years of a trial. The dose selected was loosely based on the gross size of the thyroid gland. Routine antithyroid drug therapy was given for a minimum ...

2017
Jonathan Wadsley Rebecca Gregory Glenn Flux Kate Newbold Yong Du Laura Moss Andrew Hall Louise Flanagan Sarah R Brown

Treatment options for patients with thyroid cancer that is no longer sensitive to iodine therapy are limited. Those treatments which currently exist are associated with significant toxicity. The SELIMETRY trial (EudraCT No 2015-002269-47) aims to investigate the role of the MEK inhibitor Selumetinib in resensitizing advanced iodine refractory differentiated thyroid cancer to radioiodine therapy...

Journal: :Clinical endocrinology 2003
C Dragoiescu O S Hoekstra D J Kuik P Lips M A B D Plaizier P T R Rodrigus D A K C J M Huijsmans J G Ribot J Kuijpens J W W Coebergh G J J Teule

BACKGROUND Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized trials on the latter application are considered impossible due to anticipated formidable sample sizes required in a disease with an overall excellent prog...

Journal: :JAMA otolaryngology-- head & neck surgery 2013
Grace L Nimmons Gerry F Funk Michael M Graham Nitin A Pagedar

IMPORTANCE Patients who undergo radiographic studies with contrast receive an enormous bolus of iodine. This can delay subsequent use of radioactive iodine (RAI) therapy because the iodine can compete for uptake. There is a paucity of literature on the minimum interval between contrast administration and RAI therapy. OBJECTIVE To better characterize how long it takes for the iodine load from ...

Journal: :Proceedings of the Royal Society of Medicine 1921

Journal: :Journal of Nuclear Medicine & Radiation Therapy 2012

Journal: :Radiology and Medical Diagnostic Imaging 2020

Journal: :Acta Radiologica: Therapy, Physics, Biology 1964

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید